Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway
Abstract Objective To determine the pharmacodynamic mechanism underlying Cordyceps sinensis relief in a murine model of non-small cell lung cancer (NSCLC). Methods We created a murine model of NSCLC and studied the potential molecular mechanism by which C. sinensis relieved NSCLC using a combination...
Saved in:
Main Authors: | Tianming Lu (Author), Lirun Zhou (Author), Zheng Chu (Author), Yang Song (Author), Qixin Wang (Author), Minghong Zhao (Author), Chuanhao Dai (Author), Lin Chen (Author), Guangqing Cheng (Author), Jigang Wang (Author), Qiuyan Guo (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-omics strategy reveals that Cordyceps sinensis ameliorates sepsis-associated acute kidney injury via reprogramming of mitochondrial energy metabolism and macrophage polarization
by: Lin Chen, et al.
Published: (2024) -
Research progress on pharmacological actions and molecular mechanisms of Anemoside B4
by: Tianming Lu, et al.
Published: (2023) -
Bioactive components of Cordyceps sinensis
by: Aleksandra Karmańska, et al.
Published: (2022) -
Cordyceps sinensis (yarsagumba): Pharmacological properties of a mushroom
by: Sanjukta Sen, et al.
Published: (2023) -
Effects of polysaccharides from Cordyceps sinensis mycelium on physical fatigue in mice
by: Feng Yan, et al.
Published: (2012)